UK’s CMA may accept Synopsys/Ansys deal remedies

UK’s CMA may accept Synopsys/Ansys deal remedies

Investing.com — The UK’s Competition and Markets Authority (CMA) said it may accept the remedies offered by Synopsys (NASDAQ:SNPS) and Ansys (NASDAQ:ANSS). The agency now has until until March 5,…